27 Sep 2013

EMA – European Medicines Agency organising workshop on biosimilars

The European Medicines Agency is holding a workshop on biosimilars on 31 October 2013 in London. The Agency is organising this workshop as part of its public-consultation exercise on its three draft revised overarching guidelines on biosimilars....

Read more
15 Aug 2013

World health report 2013: Research for universal health coverage

The main purpose of the report is to provide countries, donor agencies, international organizations and others with the information they need to help them make policy and funding decisions. The report is also offered to a wider audience, from universities, teaching hospitals and schools, to journalists and the public at large - anyone, in fact, with a professional or personal interest in international health issues....

Read more
13 Aug 2013

Speaker presentations slides from CMC Strategy Forum Europe 2013

The EBE BioManufacturing WG organised a Satellite Workshop at the CASSS CMC Strategy Forum Europe on 6 May 2013....

Read more
24 Jul 2013

EFPIA and PhRMA Release Joint Principles for Responsible Clinical Trial Data Sharing to Benefit Patients

EFPIA and PhRMA have jointly developed a set of industry principles for sharing clinical trial data. The press release underneath summarises these commitments....

Read more
09 Jul 2013

Priority Medicines for Europe and the World

On Tuesday 9th of July, the 2013 Report Priority Medicines for Europe and the World, produced by the World Health Organisation with financial and technical assistance from the European Commission, was launched in Brussels....

Read more
04 Jul 2013

Energise Biopharma in Europe – EBE 2013: Be the Innovation and Impact Annual Conference and General Assembly

By Titta Rosvall-Puplett, EBE Executive Director The European Biopharmaceutical Enterprise (EBE) held its annual conference at the Square Brussels Meeting Centre on 24 June 2013....

Read more
03 Jul 2013

Future of Open and Collaborative Research

Strengthening the Participation of Innovative Small and Medium Sized Enterprises- Horizon 2020: European Framework Programme 8. Horizon 2020 is the financial instrument implementing the Innovation Union, A Europe 2020 flagship initiative aimed at securing Europe's global competitiveness....

Read more
12 Apr 2013

Energising Biopharma in Europe: Collaboration breeds innovation

By Titta Rosvall-Puplett, EBE Executive Director (Source: New European Economy - April 2013) Europe has supported the birth of the healthcare biotechnology industry. It provides significant value to medical innovation, public health and the economy, and more than 325 million patients have so far benefited from biotech medicines....

Read more
01 Dec 2012

“How to strengthen the biopharma ecosystem” : Commentary by EBE President, Dr Roberto Gradnik

By Roberto Gradnik, President of EBE and CEO of Stallergenes (Source: MedNous November/December 2013) The sustainability of the biopharmapharmaceutical sector depends on a continual flow of new startups to both feed Big Pharma's pipelines and to create the next generation of emerging mid-cap companies....

Read more
1 6 7 8